Get the Stockscreener App
0.00
100.00%
-17.16
Ikena Oncology Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
See More
Previous Close:
$17.16
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$59.90M
Revenue:
$9.16M
Net Income/Loss:
$-68.17M
P/E Ratio:
0.00
EPS:
-1.63
Net Cash Flow:
$-80.16M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$23.28
Ikena Oncology Inc Stock (IKNA) Company Profile
Name
Ikena Oncology Inc
Sector
Industry
Phone
857-343-8292
Address
50 NORTHERN AVE., BOSTON
Compare IKNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IKNA
Ikena Oncology Inc
|
0.00 | 59.90M | 9.16M | -68.17M | -80.16M | -1.63 |
|
VRTX
Vertex Pharmaceuticals Inc
|
417.31 | 105.80B | 11.70B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
650.32 | 67.70B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.65 | 57.41B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
850.60 | 51.25B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.03 | 39.86B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ikena Oncology Inc Stock (IKNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-29-24 | Downgrade | Wedbush | Outperform → Neutral |
| Sep-22-23 | Initiated | Wedbush | Outperform |
| May-04-23 | Resumed | H.C. Wainwright | Buy |
| Dec-23-21 | Initiated | H.C. Wainwright | Buy |
| May-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Apr-20-21 | Initiated | Credit Suisse | Outperform |
| Apr-20-21 | Initiated | Jefferies | Buy |
| Apr-20-21 | Initiated | William Blair | Outperform |
View All
Ikena Oncology Inc Stock (IKNA) Latest News
Analyzing recovery setups for Ikena Oncology Inc. investorsEarnings Summary Report & Free Community Consensus Stock Picks - newser.com
Understanding Ikena Oncology Inc.’s price movementWeekly Trading Summary & Free Expert Approved Momentum Trade Ideas - newser.com
How to recover losses in Ikena Oncology Inc. stockBear Alert & Fast Moving Stock Trade Plans - newser.com
What Fibonacci levels say about Ikena Oncology Inc. reboundTrade Exit Report & Low Drawdown Momentum Trade Ideas - newser.com
Will Ikena Oncology Inc. stock sustain high P E ratios2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Using fundamentals and technicals on Ikena Oncology Inc.July 2025 Fed Impact & Weekly Setup with ROI Potential - newser.com
Using R and stats models for Ikena Oncology Inc. forecastingGlobal Markets & Technical Buy Zone Confirmations - newser.com
How Ikena Oncology Inc. stock trades during market volatilityJuly 2025 Closing Moves & Stepwise Trade Execution Plans - newser.com
Will Ikena Oncology Inc. stock outperform international peers2025 Market Sentiment & Stock Market Timing Techniques - fcp.pa.gov.br
Why Ikena Oncology Inc. stock is favored by top institutionsTreasury Yields & Real-Time Volume Triggers - newser.com
How Ikena Oncology Inc. stock performs in interest rate cycles2025 Earnings Surprises & Risk Adjusted Buy/Sell Alerts - newser.com
Is Ikena Oncology Inc. stock attractive for ETFs2025 Risk Factors & High Win Rate Trade Alerts - newser.com
Chart based exit strategy for Ikena Oncology Inc.Weekly Investment Summary & Low Risk Entry Point Guides - newser.com
Will Ikena Oncology Inc. stock attract more institutional investors2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Can Ikena Oncology Inc. stock deliver strong Q4 earningsSwing Trade & Community Consensus Picks - newser.com
Applying big data sentiment scoring on Ikena Oncology Inc.2025 Momentum Check & Daily Stock Trend Reports - newser.com
Published on: 2025-11-03 05:34:45 - newser.com
How Ikena Oncology Inc. stock performs in stagflationEntry Point & High Accuracy Swing Trade Signals - newser.com
Is Ikena Oncology Inc. stock gaining market shareTrade Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
ImageneBio, Inc. (NASDAQ:IMA) Short Interest Update - Defense World
Published on: 2025-10-30 23:13:35 - newser.com
Ikena Oncology Inc Stock (IKNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.55%
1.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):